Selected Grants
Omecamtiv Mecarbil CV Outcomes Trial
Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2024 - 2028Mid-Atlantic praGmatic NETwork for Inclusive Clinical trials in emergency care (MAGNETIC)
ResearchCo Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2028Integrated Biostatistical Training for CVD Research
Inst. Training Prgm or CMEMentor · Awarded by North Carolina State University · 2022 - 2027MK1242-035-CEC
Clinical TrialPrincipal Investigator · Awarded by Merck & Co., Inc. · 2021 - 2026Role of the Splanchnic Vascular Compartment in Heart Failure with Preserved Ejection Fraction
ResearchMentor · Awarded by Doris Duke Charitable Foundation, Inc. · 2022 - 2025PARACOR-19
Clinical TrialCo Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2021 - 2025Postdoctoral Training in Cardiovascular Clinical Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2025Use and Effectiveness of Outpatient Intravenous Diuretic Therapy as Treatment for Worsening Heart Failure
ResearchMentor · Awarded by American Heart Association · 2022 - 2025Plasmonically Enhanced Point-of-care Detection of Cardiac Biomarkers by a Smart Phone
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2025Mavacamten Manuscripts
ResearchPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2021 - 2023Multidisciplinary Heart and Vascular Diseases
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2023Congestion Phenotypes and Splanchnic Nerve Modulation in Chronic Heart Failure
Clinical TrialAdvisor · Awarded by National Institutes of Health · 2020 - 2022The Feasibility of a Biomarker Guided Strategy in Anthracycline Cardiotoxicity
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2020 - 2022Characterization of Patients with Heart Failure and Patients with Vascular Disease and Atrial Fibrillation in Duke University Health System Data
ResearchPrincipal Investigator · Awarded by Bayer Corporation · 2020 - 2022DAXOR - BVA Trial
Clinical TrialPrincipal Investigator · Awarded by Daxor Corporation · 2020 - 2021A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced
Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2016 - 2021HF Clinical Research Network Regional Clinical Center (U10)
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2020INDIE-HF-pEF
Clinical TrialPrincipal Investigator · Awarded by Aries Pharmaceuticals · 2016 - 2019GDF-15 FIGHT/RD003507
ResearchPrincipal Investigator · Awarded by Roche Diagnostics · 2018 - 2019Functional Impact of GLP-1 for Heart Failure Treatment
Clinical TrialPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2006 - 2018ATHENA-HF
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2018Oral Iron Repletion effects on Oxygen Uptake in Heart Failure
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2018NEAT
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2006 - 2018CardioMEMS
Clinical TrialMentor · Awarded by Pacesetter, Inc. · 2016 - 2018GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2018GUIDing Evidence Based Therapy Using Biomarker Intensified Treatment (CCC)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017Promotion of Renal Sodium Excretion by Renal Sympathetic Denervation in Congestive Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2014 - 2015DOSE Protocol
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2011RELAX
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2011Pharmacometabolomics Research Network
ResearchInvestigator · Awarded by National Institutes of Health · 2010 - 2011Inflammation & Prognosis in Decompensated Heart Failure
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2010External Relationships
- Abbott (St. Jude Medical)
- Boehringer Ingleheim
- Bristol-Myers Squibb
- Cytokinetics, Inc.
- LivaNova, Inc.
- Medtronic Foundation
- Myovant Sciences, Inc
- Novartis
- Rocket Pharma
- Sequana
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.